论文部分内容阅读
FAST:An international,multicenter,randomized,phase Ⅱ trial of epirubicin,oxaliplatin,and capecitabin
【作 者】
：
【机 构】
：
Institute of Clinical Cancer Research,Nordwest Hospital,Frankfurt Am Main,Germany
【出 处】
：
2016年临床肿瘤学新进展学术研讨会
【发表日期】
：
2016年5期
其他文献
PALOMA-2:Primary results from a phase Ⅲ trial of palbociclib(P)with letrozole(L)compared with letroz
会议
E1505:Adjuvant chemotherapy+/-bevacizumab for early stage NSCLC-Outcomes basedon chemotherapy subset
会议
Heritage:A phase Ⅲ safety and efficacy trial of the proposed trastuzumab biosimilar Myl-1401O versus
会议
Therapy of relapsed/refractory metastatic triple-negative breast cancer(mTNBC)with an anti-Trop-2-SN
会议
Impact of primary(1o)tumor location on overall survival(OS)and progression-free survival(PFS)in pati
会议
FOLFIRINOX combined to targeted therapy according RAS status for colorectal cancer patients with liv
会议
Efficacy of palbociclib plus fulvestrant(P+F)in patients(pts)with metastatic breast cancer(MBC)and E
会议
CREST:Randomised phase Ⅲ study of stenting as a bridge to surgery in obstructingcolorectal cancer-Re
会议